2 assets in Allergic Asthma

Therapeutic assets addressing Allergic Asthma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Omalizumab Allergic Asthma	Qianfoshan Hospital	P4	BBB (76)
5-hydroxytryptophan Allergic Asthma	Indiana University	P2	CCC (53)